The active substance in Galvenox Veno is calcium dobesilate monohydrate. The drug is indicated for the treatment of symptoms of chronic venous insufficiency of the lower extremities and for the symptomatic treatment of haemorrhoids. Adult drug.
Composition of Galvenox Veno calcium dobesilate monohydrate:
Active substance: calcium dobesilate monohydrate (Calcii dobesilas monohydricus). One capsule contains 500 mg of calcium dobesilate monohydrate and excipients: microcrystalline cellulose, magnesium stearate, titanium dioxide (E 171), azorubin (E 122), quinoline yellow (E 104), gelatin.
Operation of calcium dobesilate monohydrate Galvenox Veno:
Calcium dobesylate monohydrate, the active substance in Galvenox Veno, acts on the walls of blood vessels. Firstly, it reduces the excessive permeability and fragility of blood vessels, and secondly, it increases their strength. In this way, it prevents the seepage of fluids through the walls of the vessels. In addition, calcium dobesylate monohydrate accelerates the synthesis of collagen, which is an important structural element of the artery walls. Galvenox Veno also reduces blood viscosity, increases the elasticity of red blood cells and has an anti-aggregating effect. The preparation improves peripheral venous circulation, reduces stagnation in venous vessels and inhibits the development of thrombotic changes. In addition, it reduces the fragility and permeability of lymphatic vessels, improves lymphatic drainage, which reduces swelling.
The medicinal product Galvenox Veno indicated for use in the treatment of symptoms of chronic venous insufficiency of the lower extremities (symptoms: pain, cramps, feeling of heaviness in the legs, tingling, numbness in the lower limbs, skin changes related to venous stasis, varicose veins of the lower limbs, edema associated with chronic venous insufficiency) and in the symptomatic treatment of haemorrhoids. Adult drug.
Calcium dobesilate monohydrate Additional information:
Store the product out of reach of children, at room temperature. It is recommended to protect against moisture and light. Caution should be exercised in the case of active gastric ulcer and / or duodenal ulcer, as well as chronic gastritis (it is recommended to periodically check the function of the stomach and duodenum); when the symptoms worsen, stop taking the drug and contact your doctor. Use in people with impaired renal function: in cases of severe renal insufficiency (especially in dialysis patients) it is recommended to use lower doses. Use during pregnancy and breastfeeding: during pregnancy, the drug can be used only on the recommendation of a doctor, when the potential benefit of the drug exceeds the possible risk to the fetus, and the drug is contraindicated in the first trimester of pregnancy. Use during breastfeeding should be discussed with your doctor. The drug is excreted in milk in a small amount. The drug contains azorubine (E122) - this component may cause allergic reactions.
Do not use in case of hypersensitivity to any component of the drug. Do not use in children. Do not use in the first trimester of pregnancy.
Some people may experience side effects while taking the drug. Rare: epigastric pain, nausea, diarrhea, vomiting, skin reactions, arthralgia, headache, dizziness, fever. Very rare: Bone marrow suppression with agranulocytosis (an acute condition which may be manifested by high fever, mouth infections or inflammation of the anus and genitals) - stop taking the drug and contact your doctor. Local allergic reactions (rashes) and systemic reactions (urticaria) have also been reported. Usually the side effects disappear when the drug is stopped or the dose reduced.
Dosage of Galvenox Veno calcium dobesilate monohydrate capsules:
Use as directed by your doctor or as indicated on the leaflet. The recommended dose for adults: unless otherwise prescribed by a doctor, the usual dose is 1-2 capsules (500-1000 mg). Duration of treatment: from several weeks to several months. Swallow the capsule whole. Use with main meals. Do not exceed the indicated doses.